Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
Diabetes, Obesity & Metabolism|February 19, 2014
Mortality risk with sulphonylureas compared to metforminS E Holden, C J CurrieDiabetes, Obesity & Metabolism|January 14, 2014
How many people inject insulin? UK estimates from 1991 to 2010S E Holden, E A M Gale, S Jenkins-Jones, et al.Diabetes, Obesity & Metabolism|April 26, 2014
Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortalityC Ll Morgan, J Mukherjee, S Jenkins-Jones, et al.Diabetes, Obesity & Metabolism|November 18, 2014
Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancerS E Holden, S Jenkins-Jones, C Ll Morgan, et al.Diabetes, Obesity & Metabolism|April 12, 2014
Association between first-line monotherapy with sulphonylurea versus metformin and risk of all-cause mortality and cardiovascular events: a retrospective, observational studyC Ll Morgan, J Mukherjee, S Jenkins-Jones, et al.Diabetic Medicine : a Journal of the British Diabetic Association|February 8, 2017
Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013S E Holden, S Jenkins-Jones, C Ll Morgan, et al.Diabetes, Obesity & Metabolism|July 22, 2014
Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controlsC A Bannister, S E Holden, S Jenkins-Jones, et al.Diabetes, Obesity & Metabolism|July 9, 2011
The safety profile of exogenous insulin in people with type 2 diabetes: justification for concernC J Currie, J A JohnsonDiabetic Medicine : a Journal of the British Diabetic Association|June 1, 1997
Estimation of unascertained diabetes prevalence: different effects on calculation of complication rates and resource utilizationC J Currie, J R PetersDrug Safety|February 15, 2000
Use of routine healthcare data in safe and cost-effective drug useC J Currie, T M MacDonaldPageof 6